These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux]. Aguirre C, Haramburu F. Therapie; 1995; 50(6):563-9. PubMed ID: 8745957 [Abstract] [Full Text] [Related]
10. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers. Fleuranceau-Morel P. Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550 [Abstract] [Full Text] [Related]
14. Patient reporting of adverse drug reactions: useful information for pain management? Jarernsiripornkul N, Krska J, Richards RM, Capps PA. Eur J Pain; 2003; 7(3):219-24. PubMed ID: 12725844 [Abstract] [Full Text] [Related]
15. [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. Imbs JL, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac JP, Bégaud B. Therapie; 1999; 54(1):21-7. PubMed ID: 10216418 [Abstract] [Full Text] [Related]
17. Food and Drug Administration monitoring of adverse drug reactions. Sills JM, Tanner LA, Milstien JB. Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612 [Abstract] [Full Text] [Related]
18. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria. Getov I, Dimitrova Z. Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144 [Abstract] [Full Text] [Related]